Quoin Pharmaceuticals DRC company info

What does Quoin Pharmaceuticals DRC do?
Quoin Pharmaceuticals (NASDAQ:QNRX) focuses primarily on developing innovative treatments for rare and serious diseases. This company, with its dedication to addressing unmet medical needs, is active in various stages of research and development. Quoin Pharmaceuticals' portfolio includes projects aimed at tackling conditions that currently lack sufficient treatment options, highlighting its commitment to improving patient outcomes. Their objective is not just to advance healthcare but to revolutionize it by bringing forward novel therapies that can significantly impact people's lives. Quoin Pharmaceuticals trades exclusively on the NASDAQ stock exchange under the ticker symbol QNRX, reflecting its position within the global financial market and highlighting its accessibility to investors interested in contributing to healthcare advancements.
Quoin Pharmaceuticals DRC company media
Company Snapshot

Is Quoin Pharmaceuticals DRC a public or private company?

key
Ownership
Public

How many people does Quoin Pharmaceuticals DRC employ?

people
Employees
5

What sector is Quoin Pharmaceuticals DRC in?

pie chart
Sector
Health Care

Where is the head office for Quoin Pharmaceuticals DRC?

location pin
Head Office
Ashburn, United States

What year was Quoin Pharmaceuticals DRC founded?

founded flag
Year Founded
1986
What does Quoin Pharmaceuticals DRC specialise in?
/Pain Management /Non-addictive Remedies /Post-operative Care /Drug Development /Sublingual Formulations /Pharmaceutical Research

What are the products and/or services of Quoin Pharmaceuticals DRC?

Overview of Quoin Pharmaceuticals DRC offerings
Development of innovative treatments for rare and orphan diseases, prioritizing conditions with significant unmet medical needs.
Research and production of dermatological solutions to address severe skin diseases and conditions.
Creation of advanced pain management drugs aimed at chronic and acute conditions, enhancing patient quality of life.
Expansion into pediatric medicines, focusing on developing safe and effective treatments for children with rare diseases.
Partnership with other pharmaceutical companies for the co-development and licensing of groundbreaking medical therapies.
Investment in biotechnology advancements to support the creation of novel drug delivery systems and improve therapeutic outcomes.

Who is in the executive team of Quoin Pharmaceuticals DRC?

Quoin Pharmaceuticals DRC leadership team
  • Dr. Michael  Myers Ph.D.
    Dr. Michael Myers Ph.D.
    Co-Founder, CEO & Chairman
  • Ms. Denise  Carter
    Ms. Denise Carter
    Co-Founder, COO & Director
  • Mr. Gordon Bruce Dunn J.D.
    Mr. Gordon Bruce Dunn J.D.
    Chief Financial Officer